PHARMAC responds to the RMI's editorial [2]

New Zealand Medical Journal

Volumn 118, Issue 1217, 2005, Pages

  Moodie, Peter ^a   McNee, Wayne ^a  

^a Pharmaceutical Management Agency   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

COMMERCIAL PHENOMENA; DRUG INDUSTRY; DRUG RESEARCH; LETTER; MEDICAL LITERATURE; NEW ZEALAND; PUBLICATION;

EID: 27244448089     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Metcalfe S, Dougherty S, Brougham M, Moodie P. PHARMAC measures savings elsewhere to the health sector. N Z Med J. 2003;116(1170). URL: http://www.nzma.org.nz/journal/116-1170/362/
2. Moodie P, Metcalfe S, McNee W. Response from PHARMAC: difficult choices. N Z Med J. 2003;116(1170). URL: http://www.nzma.org.nz/journal/116-1170/361/
3. Metcalfe S, Moodie P. More about cardiovascular disease and lipid management in New Zealand. N Z Med J. 2002;115(1163). URL: http://www.nzma.org.nz/journal/115-1163/203/
4. Moodie P, McNee W. PHARMAC at what cost? N Z Med J. 2000;113:64.
5. Porter R, Mulder RT, Menkes D. PHARMAC and availability of pharmaceuticals - and response. N Z Med J. 2002;115(1155):274; author reply 274-5. URL: http://www.nzma.org.nz/journal/115-1155/50/